[AT1-blocker in heart failure. Patients are readmitted more infrequently to the clinic].
D057911:Angiotensin Receptor Antagonists; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D010359:Patient Readmission / Q000706:statistics & numerical data*; D016032:Randomized Controlled Trials as Topic; D016019:Survival Analysis; D013777:Tetrazoles / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014633:Valine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D000068756:Valsartan
D057911:Angiotensin Receptor Antagonists; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine